Clinical Trial Update: Vortioxetine to Prevent Return of Symptoms in Children With Depression [Phase 3]

View source ↗

Summary

Phase 3 trial investigating vortioxetine to prevent relapse of depressive symptoms in children with depression; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Depression | Phase 3 | Status: TERMINATED | Results posted: 2023-01-05